SHERRI VESELY: Open Payments
NPI 1053398974 · TAMA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 104 payments from 21 companies in 2025. Trend: 2023 $1,212 · 2024 $1,955 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 34 | $305 |
| ABBVIE INC. | 16 | $290 |
| AstraZeneca Pharmaceuticals LP | 9 | $227 |
| Lilly USA, LLC | 8 | $136 |
| Phathom Pharmaceuticals, Inc. | 5 | $132 |
| Novo Nordisk Inc | 5 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Astellas Pharma US Inc | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
Products named: VRAYLAR, JARDIANCE, NURTEC ODT, VOQUEZNA, FARXIGA, BREZTRI, ELIQUIS, Kerendia.
Industry payments across IA — which companies pay providers there.
